Anxiolytic-like effect of milnacipran in the four-plate test in mice: mechanism of action.
Michel Bourin, Fabienne Masse, Eric Dailly, Martine Hascoët
Index: Pharmacol. Biochem. Behav. 81(3) , 645-56, (2005)
Full Text: HTML
Abstract
Milnacipran is a serotonin/noradrenaline reuptake inhibitor (SNRI) which has not yet been systematically studied preclinically or clinically for the treatment of anxiety disorders. In the four-plate test (FPT) which is known to predict anxiolytic-like activity in mice, milnacipran (4, 8, 16 and 32 mg/kg) demonstrated strong anti-punishment effects following acute administration. The anxiolytic-like effect of milnacipran was not reversed by the selective GABA(A) receptor antagonist, flumazenil (2 and 4 mg/kg), the selective alpha1-adrenoceptor antagonist, prazosin (0.5 and 2 mg/kg), the selective alpha2-adrenoceptor antagonist, idazoxan (1 and 4 mg/kg) or the selective 5-HT2B receptor antagonist, SB 206553 (0.1 and 1 mg/kg). In contrast, the selective 5-HT2A receptor antagonist, SR 46349B (0.1 and 1 mg/kg), and the non-selective 5-HT2 receptor antagonist, ketanserin (0.125 and 0.5 mg/kg), completely abolished the anxiolytic-like effect of milnacipran in FPT. Neurochemical depletion of NA or 5-HT completely abolished the activity of milnacipran. These results strongly suggest that activation of 5-HT2A receptors is critically involved in the anxiolytic activity of milnacipran. On the other hand the lack of activity of milnacipran after depletion of NA or 5-HT is consistent with milnacipran acting on the locus coeruleus to induce 5-HT release. The present data suggest a strong connection between 5-HT2A receptors and NA neurotransmission.
Related Compounds
Related Articles:
2014-12-01
[Neurobiol. Learn. Mem. 116 , 162-71, (2014)]
Role of serotonin (5-HT)2 receptors in cocaine self-administration and seeking behavior in rats.
2005-01-01
[Pharmacol. Rep. 57(1) , 35-46, (2005)]
2005-04-01
[Am. J. Physiol. Regul. Integr. Comp. Physiol. 288(4) , R909-18, (2005)]
2011-02-01
[Psychopharmacology 213(2-3) , 393-401, (2011)]
2002-01-01
[J. Neurosci. Res. 67(1) , 86-92, (2002)]